Abstract
Acromegaly is a chronic, progressive disease caused by a growth hormone (GH)-producing pituitary adenoma, resulting in elevated GH and insulin-like growth factor 1 concentrations. Following appropriate therapy (surgery, radiotherapy and/or medical treatment), many systemic GH-induced comorbid conditions improve considerably. Unfortunately, despite biochemical control, acromegaly patients suffer from a high prevalence of late manifestations of transient GH excess, significantly impairing their quality of life. In this overview article, we summarize the pathophysiology, diagnosis, clinical picture, disease course and management of skeletal complications of acromegaly, focusing on vertebral fractures and arthropathy.
Author supplied keywords
Cite
CITATION STYLE
Claessen, K. M. J. A., Mazziotti, G., Biermasz, N. R., & Giustina, A. (2016). Bone and Joint Disorders in Acromegaly. Neuroendocrinology, 103(1), 86–95. https://doi.org/10.1159/000375450
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.